Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $8.3850 (1.21%) ($8.3850 - $8.3850) on Thu. Apr. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.04% (three month average) | RSI | 48 | Latest Price | $8.3850(1.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.8% a day on average for past five trading days. | Weekly Trend | CGEN advances 0.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(70%) ARKG(69%) ARKK(65%) IWO(63%) IBB(61%) | Factors Impacting CGEN price | CGEN will decline at least -2.52% in a week (0% probabilities). VIXM(-45%) VXX(-38%) UUP(-18%) IGOV(-15%) TLT(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.52% (StdDev 5.04%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.68 | 5 Day Moving Average | $8.69(-3.51%) | 10 Day Moving Average | $8.48(-1.12%) | 20 Day Moving Average | $8.68(-3.4%) | To recent high | -39.3% | To recent low | 10% | Market Cap | $693m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |